Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s): HMTXF

Healthcare Biotechnology

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP... see more

Add To Watchlist

TSXV:HEM - Post Discussion

Hemostemix Inc > Time to diversify

View:

Post by angeloet on May 11, 2022 6:24am

Time to diversify

Really wish this was trading higher, but meh. Can't complain in this market I guess. I think we will see a major sell off at $0.40 as old investors exercise their warrants and dump them, seeing as they have probably been buying lower. Also a shet ton of warrants at $0.50, I think we will see MAJOR selling at $0.50 as old investors dump. Can't complain I guess, still a little sad with this, fully diluted we are now 50 something million market cap.

Have been taking profits and moving into BioCardia at 23 million market cap, and Caladrius at 25 million market cap, much less warrants, same stem cell therapies. Good to be diversified. I think this whole sector is so undervalued!!

265